Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 12/20 | 0.41 |
| ▸ | ABCC1 | P33527 | 5/20 | 0.39 |
| ▸ | MKNK1 | Q9BUB5 | 5/20 | 0.38 |
| ▸ | MKNK2 | Q9HBH9 | 5/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2409470 | 1.00 | ABCB1 (0.41) | ABCB1ABCC1MKNK1MKNK2CYP11B2 | |
| SCHEMBL2409214 | 0.93 | MKNK1 (0.40) | ABCB1ABCC1MKNK1MKNK2CYP11B2 | |
| SCHEMBL2409216 | 0.93 | MKNK1 (0.40) | ABCB1ABCC1MKNK1MKNK2CYP11B2 | |
| SCHEMBL2408935 | 0.90 | CYP11B2 (0.39) | ABCB1ABCC1MKNK1MKNK2CYP11B2 | |
| SCHEMBL2408934 | 0.90 | CYP11B2 (0.39) | ABCB1ABCC1MKNK1MKNK2CYP11B2 | |
| SCHEMBL2417231 | 0.88 | CYP17A1 (0.37) | ABCB1ABCC1CYP11B2CYP11B1CYP19A1 | |
| SCHEMBL2417235 | 0.88 | CYP17A1 (0.37) | ABCB1ABCC1CYP11B2CYP11B1CYP19A1 | |
| SCHEMBL2415378 | 0.87 | MKNK1 (0.40) | MKNK1MKNK2CYP11B2CYP11B1CYP19A1 | |
| SCHEMBL2415380 | 0.87 | MKNK1 (0.40) | MKNK1MKNK2CYP11B2CYP11B1CYP19A1 | |
| SCHEMBL3400945 | 0.86 | CYP11B2 (0.36) | ABCB1ABCC1MKNK1MKNK2CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8013010-B2 | 5-thioxylopyranose compounds | LABORATOIRES FOURNIER S.A. (FR) | 2011-09-06 | — | — | US | disclosed |
| US-20090186840-A1 | 5-Thioxylopyranose Compounds | LABORATOIRES FOURNIER S.A (FR) | 2009-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186840-A1 | 5-Thioxylopyranose Compounds | TPMT, PNPO, CYP3A5 | ABCB1 867/4885ABCC1 2182/4885MKNK1 2501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.